Week21, 2023
1. Influenza activity remains low, with 1.2% of specimens testing positive for influenza during week 21.
2. Among positive clinical lab specimens, 43.5% were Influenza A and 56.5% were Influenza B.
3. Public health labs reported 43 positive specimens, with 41.9% being Influenza A (92.9% H1N1, 7.1% H3N2) and 58.1% Influenza B (100% Victoria lineage).
4. Outpatient visits for ILI accounted for 1.9% of clinic visits, remaining below the national baseline, with higher rates in children aged 0-4 years (5.9%).
5. Hospitalization data reported 927 influenza-related admissions for week 21; no further updates on cumulative hospitalization rates beyond April 30.
6. Deaths attributed to pneumonia, influenza, or COVID-19 (PIC) were 7.0%, above the epidemic threshold of 6.3%; influenza accounted for 7 deaths.
7. No pediatric influenza-associated deaths were reported during week 21; the total for the season stands at 154.
8. Co-circulation of respiratory viruses, including SARS-CoV-2 and RSV, continues to influence respiratory illness trends.
9. No notable vaccination data trends were reported this week.
10. Flu activity is expected to remain minimal through the summer, with regional variations in respiratory illness contributions.